| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/13/2007 | US7189706 C2,5′-disubstituted and N6,C2,5′-trisubstituted adenosine derivatives and pharmaceutical compositions containing them |
| 03/13/2007 | US7189702 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | US7189562 Mononuclear phagocytes in therapeutic drug delivery |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189518 Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases |
| 03/13/2007 | US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof |
| 03/13/2007 | US7189404 Strain selection of pneumococcal surface proteins |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | US7189351 D-tagatose as an anti-biofilm agent |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2376540C Process for preparing amlodipine benzenesulphonate |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/13/2007 | CA2271026C 3-amino-propoxyphenyl derivatives |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/13/2007 | CA2253230C Antioxidant compounds |
| 03/13/2007 | CA2192899C Composition containing l-carnitine and hydroxycitric acid |
| 03/08/2007 | WO2007028133A2 Treatment and prevention of vascular dementia |
| 03/08/2007 | WO2007027974A1 Method for reducing risk of and extent of injury due to stroke in hypertensive subjects |
| 03/08/2007 | WO2007027780A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 03/08/2007 | WO2007027525A1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative |
| 03/08/2007 | WO2007027468A1 Ep2 receptor agonists for treating glaucoma |
| 03/08/2007 | WO2007027454A1 Heterocyclic dihydropyrimidine compounds |
| 03/08/2007 | WO2007026966A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | WO2007026962A1 Phenylene derivative |
| 03/08/2007 | WO2007026820A1 Utilization of hypertension/hypercardia-preventing effect of d-allose |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | WO2007026651A1 Therapeutic agent for hypertension |
| 03/08/2007 | WO2007025781A2 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 03/08/2007 | WO2007025604A1 4-chromenonyl-1,4-dihydropyridines and their use |
| 03/08/2007 | WO2007025595A1 Use of soluble guanylate cyclase activators for treating reperfusion damage |
| 03/08/2007 | WO2007009395A8 Schisandrin b preparation |
| 03/08/2007 | WO2006138266A3 The preparation and use of compounds as aspartyl protease inhibitors |
| 03/08/2007 | WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 03/08/2007 | WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/08/2007 | US20070054934 Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054901 Dihydrothiazine prodrugs of thiazolium agents |
| 03/08/2007 | US20070054886 Ras antagonists for treating neurodegenerative disorders |
| 03/08/2007 | US20070054866 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 03/08/2007 | US20070054861 Therapeutic uses of SMR1 peptides |
| 03/08/2007 | US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/08/2007 | US20070054364 Polypeptide variants |
| 03/08/2007 | US20070054328 Methods |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070053999 5.0%-70.0% by weight Radix Salviae Miltiorrhizae extract;10.0%-85.0% by weight Radix Notoginseng extract;5.0%-70.0% by weight Radix Astragali extract; and1.0%-15.0% by weight Borneol or oil of Lignum Dalbergiae Odoriferae; combined therapy with reduced side effects |
| 03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
| 03/08/2007 | US20070053884 Novel adult tissue-derived stem cell and use thereof |
| 03/08/2007 | DE102005042544A1 Beeinflussung des kardialen Fc-Rezeptors zur Behandlung der dilatativen Kardiomyopathie Influencing the cardiac Fc receptor for the treatment of dilated cardiomyopathy |
| 03/08/2007 | CA2621226A1 Methods for using and identifying modulators of delta-like 4 |
| 03/08/2007 | CA2621017A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 03/08/2007 | CA2620846A1 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 03/08/2007 | CA2620742A1 Thiomorpholine compound and process for preparing the same |
| 03/08/2007 | CA2620553A1 Therapeutic agent for hypertension |
| 03/08/2007 | CA2619284A1 Novel crystalline form of a pyridazino [4,5-b] indole derivative |
| 03/08/2007 | CA2615866A1 4-chromenonyl-1,4-dihydropyridines and their use |
| 03/08/2007 | CA2614088A1 Use of soluble guanylate cyclase activators for treating reperfusion damage |
| 03/08/2007 | CA2602442A1 Ep2 receptor agonists for treating glaucoma |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1759695A1 Lactate containing pharmaceutical composition and uses thereof |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758909A1 Furanopyrimidine compounds effective as potassium channel inhibitors |
| 03/07/2007 | EP1758891A2 Benzimidazolone carboxylic acid derivatives |
| 03/07/2007 | EP1758866A1 Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines |
| 03/07/2007 | EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 03/07/2007 | EP1758596A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 03/07/2007 | EP1758584A1 Methods for treating a mammal before, during and after cardiac arrest |
| 03/07/2007 | EP1758582A1 Amido compounds and their use as pharmaceuticals |
| 03/07/2007 | EP1513842B1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/07/2007 | EP1490097B1 Use of botulinum toxin for treating cardiovascular diseases |
| 03/07/2007 | EP1450780B1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1362052B1 Inhibitors of cruzipain and other cysteine proteases |
| 03/07/2007 | EP1352061B9 Method for inhibiting the expression of a target gene |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1266005B1 Regulation of human lipoxin a4 receptor-like protein |
| 03/07/2007 | EP1194528B1 Monoclonal antibody for factor VIII, which even when present in molar excess inactivates factor VIII only in part and a method for producing such an antibody |
| 03/07/2007 | EP1187811B1 Inhibitors of metalloproteinases |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926143A Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
| 03/07/2007 | CN1926137A Pyrrole-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1926104A Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators |
| 03/07/2007 | CN1925868A Paraoxonase-containing pharmaceutical preparation |
| 03/07/2007 | CN1925861A Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 03/07/2007 | CN1925851A Dichloroacetate combined with inotrope for heart protection |
| 03/07/2007 | CN1925842A Therapeutic foam |
| 03/07/2007 | CN1924013A Prourokinase modifier, preparation method, pharmaceutical composition, use, encoding gene, carrier containing gene and transformation cell |
| 03/07/2007 | CN1923996A Apirulina containing spirulina bioactive peptide and spirulina proteinase, preparation method and application thereof |
| 03/07/2007 | CN1923835A Polymorphs of clopidogrel hydrogensulfate |
| 03/07/2007 | CN1923820A Novel carboxylic acid derivatives, their preparation and use |
| 03/07/2007 | CN1923818A Irreversible inhibitors of tyrosine kinases |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1923803A Arginine rosmarinate, preparation method, pharmaceutical composition and use thereof |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |